Signaling Pathways - Lung Carcinoma - Inflammatory Bowel Disease
清除全部
- B2173 CP-673451Target: PDGFRSummary: PDGFRα/β抑制剂
- A1196 SGX-5231 CitationTarget: METSummary: 高度选择性的、ATP竞争性的Met抑制剂
- A1821 Ki8751Target: VEGFRSummary: VEGFR-2有效的、选择性抑制剂
- A3712 PF-04217903 methanesulfonateTarget: c-METSummary: c-Met抑制剂
- A4138 Tofacitinib (CP-690550,Tasocitinib)1 Citation中文名: 托法替尼,托法替布Target: JAKSummary: Janus激酶抑制剂